The Pityriasis Lichenoides I./ La Pitiriasis Liquenoide I.
 

 

Home Page

About Dermagic

Contact Dermagic

Next Edition

Past Editions

Secret X files 

The Pityriasis Lichenoides I./ La Pitiriasis Liquenoide I.  

DATA-MEDICOS 
DERMAGIC/EXPRESS 2-(85)
11 Diciembre 1.999 11 December 1.999 

~ La pitiriasis Liquenoide ~ 
~ The Pityriasis Lichenoides ~ 

EDITORIAL ESPANOL 
================= 
Hola Amigos, DERMAGIC de nuevo en la red. Hace una semana se comento en la lista 
DERMLIST Brazil el tema de la PITIRIASIS LIQUENOIDE, el Dr. George Leal me 
pidio que hiciera una revision del tema, y alli va. Hay 2 variantes: La PITIRIASIS 
LIQUENOIDE ET VARIOLIFORME AGUDA (MUCHA HABERMANN) Y 
LA PITIRIASIS LIQUENOIDE CRONICA. Si examinan bien las referencias 
Bibliograficas notaran que AMBAS pueden estar asociada a malignidad o ser el 
comienzo de la misma. De dificil tratamiento y curso imprevisto, un sindrome 
paraneoplasico ???, una manifestacion cutanea de una futura malignidad ??? alli les dejo 
estas 41 referencias. 


Saludos a todos,,, 

Dr. Jose Lapenta R. 

EDITORIAL ENGLISH 
================= 
Hello Friends, DERMAGIC again in the net. Tha past week in the list DERMLIST 
(Brazil) its speak the topic of the PITYRIASIS LICHENOIDES, the Dr. George Leal 
request me a revision of the topic, and there it goes. There are 2 variants of the disease: 
The PITYRIASIS LICHENOIDES ET VARIOLIFORMIS ACUTA (MUCHA 
OF HABERMANN) AND THE PITYRIASIS LICHENOIDES CHRONICA. If 
you examine the Bibliographical references well you will noticed that BOTH can be 
associated to malignancy or being the beginning of the same one. Of difficult treatment 
and accidental course, A paraneoplastic syndrome ???, a cutaneous manifestation of a 
future malignancy??? there I leave you these 41 references. 


Greetings to all, 

Dr. Jose Lapenta R.,,, 
================================================================== 
REFERENCIAS BIBLIOGRAFICAS / BIBLIOGRAPHICAL REFERENCES 
================================================================== 
1.) Atypical manifestations of pityriasis lichenoides chronica: development into 
paraneoplasia and non-Hodgkin lymphomas of the skin. 
2.) Comparative clinicopathological study on pityriasis lichenoides 
chronica and small plaque parapsoriasis. 
3.) The transformation of pityriasis lichenoides chronica into parakeratosis variegata in an 
11-year-old girl. 
4.)Immunopathologic studies in pityriasis lichenoides. 
5.)Psoralens and ultraviolet A therapy of pityriasis lichenoides. 
6.) Phototherapy of pityriasis lichenoides. 
7.) Long-term follow-up of photochemotherapy in pityriasis lichenoides. 
8.) [Ulcers of the tongue, pityriasis lichenoides and primary parvovirus B19 infection] 
9.) The relation between toxoplasmosis and pityriasis lichenoides chronica. 
10.) Pityriasis lichenoides in children: clinicopathologic review of 22 patients. 
11.) Pityriasis lichenoides in children: a long-term follow-up of eighty-nine cases. 
12.) Pityriasis lichenoides in children: therapeutic response to erythromycin. 
13.) [Pityriasis lichenoides in a sibling pair] 
14.) Cutaneous T-cell lymphoma (parapsoriasis en plaque). An association with pityriasis 
lichenoides et varioliformis acuta in young children. 
15.) Pityriasis lichenoides et varioliformis acuta in HIV-1+ patients: a marker of early 
stage disease. The Military Medical Consortium for the Advancement of Retroviral 
Research (MMCARR). 
16.) [Lichenoid pityriasis. Clinical study of 13 cases]. 
17.) Immunopathology of pityriasis lichenoides acuta. 
18.) Pityriasis lichenoides et varioliformis acuta in pregnancy: a case report. 
19.) Mucha-Habermann disease and its febrile ulceronecrotic variant. 
Author 
20.) Febrile ulceronecrotic Mucha-Habermann disease: a case report and review of the 
literature. 
21.) Febrile ulceronecrotic pityriasis lichenoides et varioliformis acuta. 
22.) Mucha-Habermann disease-like eruptions due to Tegafur. 
23.) [Parakertosis variegata after pityriasis lichenoides et varioliformis acuta]. 
24.) Methotrexate treatment of pityriasis lichenoides and lymphomatoid papulosis. 
25.) Pityriasis lichenoides and lymphomatoid papulosis. 
26.) Clinical and histologic differentiation between lymphomatoid papulosis and pityriasis 
lichenoides. 
27.) Lymphomatoid papulosis/pityriasis lichenoides in two children. 
28.) Immunohistology of pityriasis lichenoides et varioliformis acuta and 
pityriasis lichenoides chronica. Evidence for their interrelationship with 
lymphomatoid papulosis. 
29.) Lymphomatoid papulosis: clinicopathological comparative study with 
pityriasis lichenoides et varioliformis acuta. 
30.) Examination of cutaneous T-cell lymphoma for human herpesviruses by 
using the polymerase chain reaction 
31.) Molecular diagnosis of lymphocytic infiltrates of the skin. 
32.) Gene rearrangements and T-cell lymphomas. 
33.)Lymphomatoid papulosis associated with pityriasis lichenoides et 
varioliformis acuta with transition in a large-cell anaplastic cutaneous 
Ki-1 lymphoma. Treatment with alpha-interferon 
34.) Pityriasis lichenoides chronica with acral distribution mimicking 
palmoplantar syphilid. 
35.) Pityriasis lichenoides and acquired toxoplasmosis. 
36.) Paraneoplastic pityriasis lichenoides chronica. 
37.) Cutaneous T-cell lymphoma presenting with 'segmental pityriasis lichenoides 
chronica'. 
38.) Successful long-term use of cyclosporin A in HIV-induced pityriasis 
lichenoides chronica [letter] 
39.) Pityriasis lichenoides chronica resolving after tonsillectomy. 
40.) Segmental pityriasis lichenoides chronica. 
41.) Pityriasis lichenoides et varioliformis acuta and group-A beta 
hemolytic streptococcal infection. 
============================================================ 
1.) Atypical manifestations of pityriasis lichenoides chronica: development 
into paraneoplasia and non-Hodgkin lymphomas of the skin. 
============================================================ 
AU: Panizzon-RG; Speich-R; Dazzi-H 
AD: Department of Dermatology, University Hospital Zurich, Switzerland. 
SO: Dermatology. 184(1):65-9 1992 
PY: 1992 
PT: JOURNAL-ARTICLE 
AB-A: Three patients with atypical courses and manifestations of pityriasis 
lichenoides chronica (PLC) are presented. The first patient is a 
21-year-old white woman who showed a good response of her PLC lesions as 
well as her reactive oligoarthritis to repeated PUVA treatments combined 
with oral prednisone during 1 year. The effect of the treatment then 
decreased. The patient developed a low-grade malignant lymphoma of the 
lung. When the lymphoma of the lung improved after chemotherapy, the PLC 
eruptions improved, too. The second patient is a 41-year-old man, whose 
Hodgkin's disease stage IVa was successfully treated by chemotherapy and 
radiotherapy in 1984. In 1987 he showed PLC lesions which responded well to 
PUVA therapy, later also in combination with etretinate. Until 1988 
repeated skin biopsies revealed a non-specific eczematous pattern. In 1989 
the recalcitrant PLC eruptions finally revealed a pleomorphic non-Hodgkin 
lymphoma of the skin with medium-sized cells. The third patient had a PLC 
for about 9 years when Hodgkin's disease stage Ia was diagnosed. At the 
beginning the skin biopsy showed an eczematous pattern, but 2 years later, 
in 1990, skin infiltrations of a large-cell, anaplastic non-Hodgkin 
lymphoma were seen. These cases show that PLC in rare cases may either 
represent a paraneoplastic skin disease or may itself develop into 
cutaneous lymphomas. (Abstract from CANCERLIT) 

============================================================ 
2.) Comparative clinicopathological study on pityriasis lichenoides 
chronica and small plaque parapsoriasis. 
============================================================ 
SO - Am J Dermatopathol 1988 Jun;10(3):189-96 
AU - Benmaman O; Sanchez JL 
PT - JOURNAL ARTICLE 
AB - The term parapsoriasis refers to a group of chronic asymptomatic 
scaly dermatoses of unknown etiology about which there is still controversy 
over the nosology and nomenclature of the different conditions that 
comprise the group, particularly pityriasis lichenoides chronica (PLC) and 
small plaque parapsoriasis (SPP). In an attempt to establish the 
distinctive clinicopathologic features of these two dermatosis, we 
prospectively studied 44 patients who presented with the typical clinical 
and histologic picture of either of these two diseases. SPP was clinically 
characterized by scaly oval plaques on the trunk and proximal aspect of 
extremities. Spongiosis was the salient histopathologic feature, with 
absence of fibrosis or melanophages. PLC presented with a scaly papular 
eruption over the trunk and extremities and histologically was 
characterized by an interface dermatitis. We conclude that sufficient 
clinical and histologic features differentiate these two entities and we 
propose that the term parapsoriasis be used only to designate SPP and large 
plaque parapsoriasis. 

============================================================ 
3.) The transformation of pityriasis lichenoides chronica into parakeratosis variegata in an 
11-year-old girl. 
============================================================ 
Author 
Niemczyk UM; Zollner TM; Wolter M; Staib G; Kaufmann R 
Address 
Department of Dermatology, University of Frankfurt Medical School, Germany. 
Source 
Br J Dermatol, 137(6):983-7 1997 Dec 
Abstract 
Parakeratosis variegata is a rare disorder with unknown aetiology. In a few 
cases it arises from benign skin diseases such as pityriasis lichenoides et 
varioliformis acuta (Mucha Habermann disease) or pityriasis lichenoides 
chronica. However, transformation into malignant diseases such as cutaneous 
T-cell lymphoma has been observed. We report an 11-year-old girl with a 
10-year history of pityriasis lichenoides chronica now presenting with 
parakeratosis variegata. Analysis of skin infiltrating T cells showed 
clonally rearranged T-cell receptor gamma chains occurring with a frequency 
of more than 2%. This finding is compatible with the clinical observation 
of parakeratosis variegata transforming into a malignant T-cell disorder. 
We therefore suggest that patients suffering from parakeratosis variegata 
and other diseases such as pityriasis lichenoides et varioliformis acuta or 
pityriasis lichenoides chronica should be continuously monitored. 

============================================================ 
4.)Immunopathologic studies in pityriasis lichenoides. 
============================================================ 
SO - Arch Dermatol Res 1988;280 Suppl:S61-5 
AU - Giannetti A; Girolomoni G; Pincelli C; Benassi L 
PT - JOURNAL ARTICLE 
AB - Skin biopsy specimens from five patients with pityriasis lichenoides 
et varioliformis acuta and from six patients with pityriasis lichenoides 
chronica were studied by direct immunofluorescence and by an 
immunoperoxidase technique using a panel of monoclonal antibodies. The 
dermal inflammatory infiltrate was composed of T cells, macrophages, and a 
small proportion of CD1a+ cells, mostly perivascular. CD8+ cells 
(cytotoxic/suppressor phenotype) predominated in the epidermis according to 
the degree of epidermal necroses, whereas CD4+ cells (helper/inducer 
phenotype) were superior in number among dermal T cells. A few B cells and 
Leu7+ cells were detected in only a small proportion of lesions. The 
results obtained confirm that the two conditions are variants of a single 
disease process and suggest that cell-mediated immune mechanisms may be 
important in the pathogenesis of the epidermal and vascular damage. 
Endothelial cells (HLA-DR+ and HLA-DQ+) and CD1a+ cells (epidermal and 
possibly dermal) could be primarily involved, acting as antigen-presenting 
cells. 

============================================================ 
5.)Psoralens and ultraviolet A therapy of pityriasis lichenoides. 
============================================================ 
SO - J Am Acad Dermatol 1984 Jan;10(1):59-64 
AU - Powell FC; Muller SA 
PT - JOURNAL ARTICLE 
AB - Three patients with long-standing pityriasis lichenoides, which was 
resistant to other forms of therapy, were successfully treated with PUVA 
(psoralens and ultraviolet light of wavelength A). One patient had complete 
clearing of all lesions, and the other two had marked improvement. PUVA is 
being used to treat increasing numbers of patients with pityriasis 
lichenoides, and the results have been very good. 

============================================================ 
6.) Phototherapy of pityriasis lichenoides. 
============================================================ 
Arch Dermatol 1983 May;119(5):378-80 

LeVine MJ 
Eleven patients with chronic pityriasis lichenoides chronica were treated 
with topically applied bland emollient cream and minimally erthemogenic 
doses of UV radiation from fluorescent sunlamps. The conditions of all 
patients cleared completely in an average of 29 treatments, requiring an 
average UV dose of 388 millijoules/sq cm at clearance. Phototherapy 
provides a convenient effective outpatient therapy for pityriasis 
lichenoides chronica. 

============================================================ 
7.) Long-term follow-up of photochemotherapy in pityriasis lichenoides. 
============================================================ 
Acta Derm Venereol 1982;62(5):442-4 

Boelen RE, Faber WR, Lambers JC, Cormane RH 
Five patients with a histopathologically confirmed diagnosis of pityriasis 
lichenoides were treated with PUVA or irradiated with a light source 
emitting UVB and UVA, without prior intake of psoralens. All patients 
showed a good response to treatment. Long-term follow up showed that 
patients remained free of lesions during a period of 20 to 36 months; 3 
patients had a recurrence of the disease, though less extensive than 
before, after 25, 23, and 23 months, respectively. 

============================================================ 
8.) [Ulcers of the tongue, pityriasis lichenoides and primary parvovirus B19 infection] 
============================================================ 
Author 
Labarthe MP; Salomon D; Saurat JH 
Address 
Service de Dermatologie, H^opital Cantonal Universitaire de Gen`eve, Suisse. 
Source 
Ann Dermatol Venereol, 123(11):735-8 1996 
Abstract 
INTRODUCTION: We report a case of parapsoriasis en gouttes (or pityriasis 
lichenoides) which presents two peculiarities. First, the patient had 
lingual ulcerations and second, the eruption appeared during a 
seroconversion for Parvovirus B19. OBSERVATION: A 25 old woman presented a 
first episode of characteristic parapsoriasis en gouttes associated with 
purpuric palmoplantar lesions and lingual ulcerations, reaching deep 
muscular in histology. DISCUSSION: This observation of parapsoriasis en 
gouttes, peculiar because of lingual ulcerations, is mostly interesting 
because of its association with a primo-infection to Parvovirus B19. The 
receptor of the virus is localised on endothelial cells and that could 
explain purpuric lesions and ulcerations observed. 

============================================================ 
9.) The relation between toxoplasmosis and pityriasis lichenoides chronica. 
============================================================ 
Author 
Nassef NE; Hammam MA 
Address 
Department of Parasitology, Faculty of Medicine, Menoufia University, Egypt. 
Source 
J Egypt Soc Parasitol, 27(1):93-9 1997 Apr 
Abstract 
Pityriasis lichenoides chronica (PLC) is a rare skin disease of uncertain 
aetiology. Many infectious agents have been incriminated as the cause of 
the disease. One of these agents is toxoplasmosis. The aim of this work was 
to find out if there is a relationship between toxoplasmosis and PLC. 
Twenty two patients (17 males and 5 females) diagnosed clinically and 
histopathologically as PLC were chosen for this study. Also twenty 
apparently healthy individuals free from skin lesions were included as a 
control group. Patients and controls were examined clinically for signs of 
toxoplasmosis and submitted for indirect haemagglutination (IHA) and 
indirect immunofluorescent antibody (IFA) tests in our Parasitology 
laboratory for serodiagnosis of toxoplasmosis. Toxoplasmosis was diagnosed 
in 8 (36.36%) and 3 (15%) in PLC patients and controls respectively by both 
tests. Using pyrimethamine and trisulfapyrimidine in treating PLC patients, 
showed subsidence of skin lesions in five patients with toxoplasmosis 
within two months from the beginning of therapy. The remaining patients 
showed no response to treatment. On conclusion, toxoplasmosis appears to 
play a role in the aetiology of PLC and serological tests for diagnosing 
toxoplasmosis should be performed in all PLC patients. 

============================================================ 
10.) Pityriasis lichenoides in children: clinicopathologic review of 22 patients. 
============================================================ 
Author 
RomanŽi J; Puig L; FernŽandez-Figueras MT; de Moragas JM 
Address 
Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, 
Spain. 
Source 
Pediatr Dermatol, 15(1):1-6 1998 Jan-Feb 
Abstract 
Pityriasis lichenoides (PL) is a cutaneous disease of unknown origin, with 
an autoinvolutive course, that can occur in pediatric patients. 
Traditionally, acute and chronic variants have been described, but other 
special forms of presentation have been reported. We reviewed the clinical 
records and histopathologic specimens of all pediatric patients diagnosed 
with PL in our hospital from 1980 to 1995 to assess the clinicopathologic 
features of this disorder in our environment. Twenty-two of the 118 cases 
reviewed were pediatric patients less than 15 years old (12 males and 10 
females, 18.6% of all patients). Their ages ranged from 3 to 15 years, with 
a mean of 9.3 years. Most of the patients (72%) had the chronic variant of 
the disease, while the remainder had an acute course. One patient suffered 
from acute ulceronecrotic PL. Systemic treatments prescribed were 
erythromycin in eight patients, PUVA in five patients, and methotrexate in 
one patient. Three patients had a prolonged course with more than two 
episodes. Acute and chronic PL are polar extremes, but individual cases 
cannot be classified only on the basis of histopathologic data, since 
coexistence of lesions in different stages of evolution can lead to 
sampling bias. Acute ulceronecrotic forms and the presence of a variable 
degree of cellular atypia in the infiltrate are liable to cause 
differential diagnostic problems with lymphomatoid papulosis (LP), which 
cannot be completely resolved on the basis of T-cell receptor clonal 
rearrangement detection. 

============================================================ 
11.) Pityriasis lichenoides in children: a long-term follow-up of eighty-nine cases. 
============================================================ 
J Am Acad Dermatol 1990 Sep;23(3 Pt 1):473-8 

Gelmetti C, Rigoni C, Alessi E, Ermacora E, Berti E, Caputo R 
Department of Dermatology and Pediatric Dermatology I, University of Milan, 
Italy. 

Pityriasis lichenoides is usually classified into an acute and a chronic 
form. From a review of 89 cases of the disease seen since 1974 it seems 
that a more realistic classification into three main groups, according to 
the distribution of pityriasis lichenoides lesions, could be made, namely, 
a diffuse, a central, and a peripheral form, each characterized by a 
different clinical course. Conversely, no correlations were detected in our 
series between the severity of skin lesions and their distribution or the 
overall course of the disease. None of our cases suggests the possible 
evolution of pityriasis lichenoides into lymphomatoid papulosis. Although 
no infectious causative agent has been identified, a viral origin seems 
likely in some cases. Most patients responded favorably to UVB irradiation. 
Our conclusions are (1) that pityriasis lichenoides is probably a clinical 
disorder with a diverse etiology and (2) that its classification by 
distribution seems more useful than its subdivision into an acute and a 
chronic form. 

============================================================ 
12.) Pityriasis lichenoides in children: therapeutic response to erythromycin. 
============================================================ 
J Am Acad Dermatol 1986 Jul;15(1):66-70 

Truhan AP, Hebert AA, Esterly NB 
Fifteen of twenty-two children with pityriasis lichenoides were treated 
with oral erythromycin. Eleven (73%) had a remission, usually within 2 
months. Two others showed partial improvement, and two were unimproved. 
Seven of the children who experienced a remission were off erythromycin and 
free of lesions after 2 to 5 months of therapy. A trial of erythromycin as 
described herein should be considered in children with pityriasis 
lichenoides before other, possibly more toxic, measures are instituted. 

============================================================ 
13.) [Pityriasis lichenoides in a sibling pair] 
============================================================ 
ARTICLE SOURCE: Hautarzt (Germany, West), Nov 1981, 32(11) p592-4 
AUTHOR(S): Deuchert C 
PUBLICATION TYPE: JOURNAL ARTICLE 
ABSTRACT: Two brothers are reported, who had pityriasis lichenoides within 
an interval of eighteen months. The hitherto unknown etiology of this 
dermatosis is discussed. 

============================================================ 
14.) Cutaneous T-cell lymphoma (parapsoriasis en plaque). An association with pityriasis 
lichenoides et varioliformis acuta in young children. 
============================================================ 
Authors 
Fortson JS. Schroeter AL. Esterly NB. 
Institution 
Department of Dermatology, Wright State University School of Medicine, 
Dayton, Ohio 45401-0927. 
Source 
Archives of Dermatology. 126(11):1449-53, 1990 November. 
Abstract 
Pityriasis lichenoides et varioliformis acuta (PLEVA) and pityriasis 
lichenoides chronica (PLC) are related benign disorders without recognized 
association with cutaneous T-cell lymphoma (CTCL). We report the cases of 
two children with documented PLEVA evolving into CTCL over several years. 
One child had the clinical lesions of PLC but the dermatopathologic 
findings of PLEVA at age 2 years. At age 12 years, he had skin changes of 
poikiloderma atrophicans vasculare and dermatopathologic findings 
consistent with parapsoriasis en plaque. The second child presented at age 
7 years with scaling dermatitis and dermatopathologic findings of PLEVA. At 
age 12 years, the histologic diagnosis was parapsoriasis. Monoclonal 
antibody studies performed on biopsy specimens from both patients revealed 
70% to 100% cells staining with CD5, 80% to 90% staining with CD4, 30% to 
50% staining with CD8, and an increase in CD1-staining cells in the 
papillary dermis, indicating a predominantly helper T-cell infiltrate. We 
believe that PLC and PLEVA may be part of the spectrum of CTCL. 
Furthermore, CTCL may be more common in young children than once thought. 

============================================================ 
15.) Pityriasis lichenoides et varioliformis acuta in HIV-1+ patients: a marker of early 
stage disease. The Military Medical Consortium for the Advancement 
of Retroviral Research (MMCARR). 
============================================================ 
Author 
Smith KJ; Nelson A; Skelton H; Yeager J; Wagner KF 
Address 
Medical Research Institute of Chemical Defense, Aberdeen, Maryland, USA. 
Source 
Int J Dermatol, 36(2):104-9 1997 Feb 
Abstract 
BACKGROUND: The high incidence of cutaneous disease in HIV-1+ patients may 
be a marker of the chronic state of immune activation. In addition, 
specific cutaneous diseases may be related to the pattern and degree of 
immune dysregulation present in the patients at the time of the eruption. 
We have observed that HIV-1+ patients with pityriasis lichenoides et 
varioliformis acuta (PLEVA) were in the early to midstage of HIV-1 disease. 
MATERIALS AND METHODS: To determine if there was a correlation between the 
phenotype of the lymphoid infiltrate and surface markers of the epidermis 
and the known changes in early or late-stage HIV-1 disease, we studied five 
HIV-1+ patients with PLEVA. Cutaneous biopsy specimens were obtained and 
immunohistochemical stains were used to determine the expression of ELAM-1, 
ICAM-1, and HLA-DR and the phenotype of the lymphoid infiltrate. RESULTS: 
The HIV-1+ patients showed increased expression of HLA-DR on keratinocytes 
as well as on the mononuclear and dendritic cell populations in the 
epidermis and dermis. The majority of T cells were activated CD8+ cells. 
CONCLUSIONS: Immunophenotyping of the inflammatory infiltrate in these 
patients is consistent with a pattern of immune dysregulation seen only in 
earlier stages of HIV-1 disease. Thus, PLEVA may be useful as a marker of 
early to midstages of HIV-1 disease. 

============================================================ 
16.) [Lichenoid pityriasis. Clinical study of 13 cases]. 
============================================================ 
Med Cutan Ibero Lat Am 1977;5(3):189-96 
[Article in Spanish] 

Bravo Piris J 
13 patients with Pityriasis Lichenoides are studied clinical and 
histologically, showing a clinical polymorphism of the lesions, mainly in 
the papulous, vesiculous, and necrotic ones. The data about age, sex, 
evolution and response to the treatment in the present study are similar to 
those found by other authors. Constantly, we found, a variable degree of 
vasculitis. In almost all the cases there was a damage of the epithelium 
--exoserosis and exocytosis--, as well as presence in some cases, of red 
cells extravasated within the epidermis. In upper dermis we found in all 
biopsies, divers degrees of perivascular cell infiltration mainly composed 
of lymphocytes and histiocytes with predominance of the last ones, in five 
cases. In the majority of our cases, there was a strong relationship 
between the clinical and the histological aspects, but in some cases, mild 
lesions showed an acute microscopical picture. We are of the opinion that 
Pityriasis Lichenoides must be considered as a different entity from 
Parapsoriasis. In addition, we think that PL, is a clinical picture that 
manifests itself as a chronic or an acute form, and both types can be seen 
in the disease evolution. Finally, we could not find an evident influence 
and a positive response to the treatment in our patients with the classical 
therapeutics. 

============================================================ 
17.) Immunopathology of pityriasis lichenoides acuta. 
============================================================ 
ARTICLE SOURCE: J Am Acad Dermatol (United States), May 1984, 10(5 Pt 1) 
p783-95 
AUTHOR(S): Muhlbauer JE; Bhan AK; Harrist TJ; Moscicki RA; Rand R; 
Caughman W; Loss B; Mihm MC Jr 
PUBLICATION TYPE: JOURNAL ARTICLE 
ABSTRACT: Eleven biopsy specimens (five papules and six dusky or crusted 
lesions) from four patients with pityriasis lichenoides et varioliformis 
acuta ( PLEVA ) were studied by direct immunofluorescence and 
immunoperoxidase technics. Slight vascular deposits of IgM and C3 were 
present in most lesions. Slight perivascular deposits of fibrin were 
observed in early lesions; more extensive perivascular and interstitial 
deposits of fibrin were detected in advanced lesions. Most of the 
infiltrating cells were T lymphocytes; cells with cytotoxic/suppressor 
phenotype (T8-positive) were generally more numerous than cells with 
helper/inducer phenotype (Leu-3a-positive, T4-positive). A marked increase 
in epidermal T8-positive cells over epidermal Leu-3a/T4-positive cells was 
found in late lesions. Moreover, a reduction of the ratio of circulating 
T4-positive to T8-positive cells was observed in most cases. The number of 
epidermal T6-positive (Langerhans/indeterminate) cells was decreased in the 
lower as compared with the upper stratum spinosum. About 5% of perivascular 
infiltrating cells were T6-positive. These results suggest that 
cell-mediated immune mechanisms are probably important in the pathogenesis 
of PLEVA 

============================================================ 
18.) Pityriasis lichenoides et varioliformis acuta in pregnancy: a case report. 
============================================================ 
Author 
Fukada Y; Okuda Y; Yasumizu T; Hoshi K 
Address 
Department of Obstetrics and Gynecology, Yamanashi Medical University, Japan. 
Source 
J Obstet Gynaecol Res, 24(5):363-6 1998 Oct 
Abstract 
If pityriasis lichenoides et varioliformis acuta (PLAVA) exists in the 
vagina or cervical os of the uterus, it may cause premature labor and 
premature rupture of the membranes. 

============================================================ 
19.) Mucha-Habermann disease and its febrile ulceronecrotic variant. 
Author 
============================================================ 
Tsuji T; Kasamatsu M; Yokota M; Morita A; Schwartz RA 
Address 
Department of Dermatology, Nagoya City University Medical School, Nagoya, 
Japan. 
Source 
Cutis, 58(2):123-31 1996 Aug 
Abstract 
In 1916 Mucha and in 1925 Habermann reported an acute form of pityriasis 
lichenoides characterized by the abrupt onset of papulovesicular eruptions 
and gave the name, pityriasis lichenoides et varioliformis acuta (PLEVA) or 
Mucha-Habermann disease (MH). In 1966, Degos reported a rare febrile 
ulceronecrotic variant of MH. MH occurs mainly in young adults, while 
febrile ulceronecrotic Mucha-Habermann's disease (FUMHD) occurs more 
frequently in children. The etiology of MH remains obscure, but it may be 
the result of a hypersensitivity reaction to an infectious agent. Although 
clinical and histologic features of the disease in children are similar to 
those of adults, more diseases need to be differentiated in pediatric 
patients. In addition, a number of effective therapeutic options in adults 
with MH are unsuitable for use in pediatric patients, to whom beginning 
with oral antibiotics, usually erythromycin, is recommended. A summary of 
previously reported fifteen cases with FUMHD, including our case, is listed. 

============================================================ 
20.) Febrile ulceronecrotic Mucha-Habermann disease: a case report and review of the 
literature. 
============================================================ 
Author 
SuŽarez J; LŽopez B; Villalba R; Perera A 
Address 
Section of Dermatology, Hospital La Candelaria, Santa Cruz de Tenerife, 
Spain. 
Source 
Dermatology, 192(3):277-9 1996 
Abstract 
A 32-year-old male with febrile ulceronecrotic Mucha-Habermann disease 
(FUMHD) responsive to methotrexate is reported. This is a severe variant of 
pityriasis lichenoides et varioliformis acuta characterized by the acute 
onset of a widespread ulceronecrotic cutaneous eruption together with high 
fever and systemic involvement. To our knowledge, only 13 patients with 
FUMHD have been reported to date. 

============================================================ 
21.) Febrile ulceronecrotic pityriasis lichenoides et varioliformis acuta. 
============================================================ 
Dermatology 1994;189 Suppl 2:50-3 

De Cuyper C, Hindryckx P, Deroo N 
Algemeen Ziekenhuis Sint-Jan, Ruddershove, Brugge, Belgium. 

An unusually severe form of pityriasis lichenoides et varioliformis acuta 
(PLEVA) with a fatal outcome in an 82-year-old woman is reported. After a 
period of a mild eruption, extensive polymorphous, papular and 
ulcerohemorrhagic skin lesions developed, associated with intermittent high 
temperature and constitutional symptoms. Skin biopsies showed the typical 
histopathological changes of PLEVA. Early recognition of this severe 
variant of PLEVA is important, since the fulminating course can lead to 
death. 

============================================================ 
22.) Mucha-Habermann disease-like eruptions due to Tegafur. 
============================================================ 
Author 
Kawamura K; Tsuji T; Kuwabara Y 
Address 
Department of Dermatology, Nagoya City University Medical School, Japan. 
Source 
J Dermatol, 26(3):164-7 1999 Mar 
Abstract 
The first case of Mucha-Habermann disease-like drug eruptions due to 
Tegafur is reported. A 59-year-old man noticed various skin lesions after 
he had taken 300 mg of Tegafur daily for about 200 days. The patient had 
papulonecrotic eruptions on his trunk and extremities. The histology from a 
papular lesion revealed epidermal necrosis surrounded by spongiosis, 
perivascular inflammatory infiltrations composed of lymphocytes and 
erythrocytes, and endothelial swelling. The etiology of Mucha-Habermann 
disease is not known, but an immune mechanism may be supported by our case. 

============================================================ 
23.) [Parakertosis variegata after pityriasis lichenoides et varioliformis acuta]. 
============================================================ 
Hautarzt 1995 Jul;46(7):498-501 

Kiene P, Folster-Holst R, Mielke V 
Universitats-Hautklinik, Kiel. 

We report on a 34-year-old male patient who developed generalized 
parakeratosis variegata lesions 4 years after suffering from pityriasis 
lichenoides et varioliformis acuta. For further investigation of a possible 
interrelationship between these two diseases of the parapsoriasis group and 
their relationship to the T-cell type of cutaneous non-Hodgkin-lymphoma, 
histological, immunohistological and molecular-biological techniques were 
applied. We were able to demonstrate typical morphological features common 
to both diseases, and a polyclonal T-cell infiltrate in both. It is 
concluded that pityriasis lichenoides et varioliformis acuta and 
parakeratosis variegata are separate entities without monoclonal 
rearrangement or signs of malignancy. 

============================================================ 
24.) Methotrexate treatment of pityriasis lichenoides and lymphomatoid papulosis. 
============================================================ 
Cutis 1979 May;23(5):634-6 

Lynch PJ, Saied NK 
Pityriasis lichenoides is a notoriously difficult disease to treat. Three 
patients with this condition and a fourth with lymphomatoid papulosis have 
been successfully treated with doses of methotrexate once a week. Toxicity 
noted during the treatment periods has been minimal. 

============================================================ 
25.) Pityriasis lichenoides and lymphomatoid papulosis. 
============================================================ 
Semin Dermatol 1992 Mar;11(1):73-9 

Rogers M 
Department of Dermatology, Children's Hospital, Camperdown, Australia. 

The clinical features, histopathology, immunopathology, and management of 
pityriasis lichenoides and lymphomatoid papulosis are discussed, with 
particular emphasis on the pediatric aspects of these conditions. The 
difficulties in logically separating pityriasis lichenoides into an acute 
(pityriasis lichenoides et varioliformis acuta) and a chronic (pityriasis 
lichenoides chronical) form are addressed. The development of 
lymphoreticular malignancy in patients with lymphomatoid papulosis has been 
well documented, but pityriasis lichenoides has characteristically been 
regarded as a benign condition. However, recent reports of the development 
of large plaque parapsoriasis in patients with pityriasis lichenoides have 
led to a reconsideration. Some of these patients were in the pediatric age 
group. Although there are significant clinical, histopathological, and 
immunopathological differences between pityriasis lichenoides and 
lymphomatoid papulosis, the demonstration of similar clonal T cell receptor 
gene rearrangements and the confirmation of the potentially premalignant 
nature of both suggests that there may indeed be an interrelationship 
between these two controversial entities. Close follow-up of patients with 
both of these conditions is recommended, with observation being 
discontinued only when the patient has been free of lesions for several 
years. 

============================================================ 
26.) Clinical and histologic differentiation between lymphomatoid papulosis and pityriasis 
lichenoides. 
============================================================ 
J Am Acad Dermatol 1985 Sep;13(3):418-28 

Willemze R, Scheffer E 
The relationship between lymphomatoid papulosis and pityriasis lichenoides 
is a matter of considerable debate. Differentiation between these two 
conditions is, however, important because patients with lymphomatoid 
papulosis, unlike those with pityriasis lichenoides, may develop systemic 
lymphoma and thus require long-term follow-up. In our study the clinical 
and histologic features of eighty-two patients with pityriasis lichenoides 
and twenty-six patients with lymphomatoid papulosis were reviewed and 
compared. Clinical and histologic differences were recognized, not only 
allowing differentiation between the two conditions, but also suggesting 
that they are pathogenetically distinct diseases. Finally, evidence is 
presented to suggest that the different views on the relationship between 
these diseases mainly result from differences in patient selection. 

============================================================ 
27.) Lymphomatoid papulosis/pityriasis lichenoides in two children. 
============================================================ 
Pediatr Dermatol 1987 Nov;4(3):238-41 

Ashworth J, Paterson WD, MacKie RM 
Department of Dermatology, University of Glasgow, United Kingdom. 

Two children developed lymphomatoid papulosis/pityriasis lichenoides at 
ages 3 and 6 years. Follow-up continued for 13 years in the former patient 
and for 6 years in the latter. Both children now have continuing low-grade 
disease activity requiring in the one case topical corticosteroid therapy 
and in the other low-dose systemic steroid therapy. These children are 
reported to emphasize to pediatricians, pediatric pathologists, and 
hematologists that pseudolymphomatous conditions can exist in young 
children and do not require potent cytotoxic therapy. In both of our 
patients, the initial diagnosis was thought to be an aggressive lymphoma. 

============================================================ 
28.) Immunohistology of pityriasis lichenoides et varioliformis acuta and 
pityriasis lichenoides chronica. Evidence for their interrelationship with 
lymphomatoid papulosis. 
============================================================ 
J Am Acad Dermatol 1987 Mar;16(3 Pt 1):559-70 

Wood GS, Strickler JG, Abel EA, Deneau DG, Warnke RA 
Pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides 
chronica are idiopathic, papular eruptions that exhibit certain 
clinicopathologic similarities to each other and to lymphomatoid papulosis. 
In order to determine if these disorders are also similar immunologically, 
we studied the immunopathology of five biopsy specimens from three cases of 
pityriasis lichenoides et varioliformis acuta and three biopsy specimens 
from three cases of pityriasis lichenoides chronica. We then compared them 
to our prior immunohistologic study of nine cases of lymphomatoid 
papulosis. Pityriasis lichenoides et varioliformis acuta and pityriasis 
lichenoides chronica both exhibited a dermal and epidermal infiltrate of 
CD4+ and CD8+ T cells expressing activation antigens. These were admixed 
with numerous macrophages. The lesional epidermis was diffusely human 
lymphocyte antigen (HLA)-DR+ and contained decreased CD1+ dendritic cells. 
Endothelial cells were also HLA-DR+. Cells bearing the phenotypes of B 
cells, follicular dendritic cells, or natural killer/killer cells were 
essentially absent. Except for the lack of large atypical cells, the 
results resembled those described previously for lymphomatoid papulosis. 
These findings indicate that pityriasis lichenoides chronica, pityriasis 
lichenoides et varioliformis acuta, and lymphomatoid papulosis share 
several immunohistologic features. Together with certain clinicopathologic 
similarities, they are consistent with the hypothesis that these three 
disorders are interrelated. 

============================================================ 
29.) Lymphomatoid papulosis: clinicopathological comparative study with 
pityriasis lichenoides et varioliformis acuta. 
============================================================ 
J Dermatol 1991 Oct;18(10):580-5 

Erpaiboon P, Mihara I, Niimura M 
Department of Dermatology, Jikei University School of Medicine, Tokyo, Japan. 

We have compared the clinical and histopathological features of 6 patients 
with lymphomatoid papulosis (LP) and 14 patients with pityriasis 
lichenoides et varioliformis acuta (PLEVA). There were some differences 
between the clinical features in the two diseases, including the size and 
appearance of skin lesions and the duration of the course of disease. Ki-1 
Ag positive, large, atypical, lymphoid cells were always seen in 
lymphomatoid papulosis; none of lymphoid cells of pityriasis lichenoides et 
varioliformis acuta demonstrated this antigen. We conclude that 
lymphomatoid papulosis and PLEVA, although sharing some common features, 
should be considered to be different clinical and immunopathological 
entities. 

============================================================ 
30.) Examination of cutaneous T-cell lymphoma for human herpesviruses by 
using the polymerase chain reaction 
============================================================ 
AU: Brice-SL; Jester-JD; Friednash-M; Golitz-LE; Leahy-MA; Stockert-SS; 
Weston-WL 
AD: B-153, Department of Dermatology, University of Colorado, Health 
Sciences Center, 4200 East 9th Avenue, Denver, CO 80262, United States 
SO: J-Cutan-Pathol. 20(4):304-7 1993 
CP: Denmark 
PT: JOURNAL-ARTICLE 
AB-A: The etiology of cutaneous T-cell lymphoma remains unknown, although 
an association with viral infection, in particular certain retroviruses and 
human herpesviruses, has been suggested. The purpose of this study was to 
examine skin biopsies of cutaneous T-cell lymphoma for the presence of 
Epstein-Barr virus, herpes simplex virus type 1 and type 2, and human 
herpesvirus-6 by using the polymerase chain reaction. Lesional skin 
biopsies from 30 patients with cutaneous T-cell lymphoma were studied. 
Control specimens included biopsies from 9 patients with lymphomatoid 
papulosis and 10 patients with pityriasis lichenoides et varioliformis 
acuta. DNA extracted from each specimen, as well as from a known positive 
control for each virus, was examined by using the polymerase chain reaction 
with viral-specific primers. Each DNA specimen was also amplified with 
control primers for human beta globin. The specificity of the amplified 
products was confirmed by Southern analysis. Neither Epstein-Barr virus nor 
herpes simplex virus was detected in any of the patient specimens examined. 
Human herpesvirus-6 was detected in one specimen of cutaneous T-cell 
lymphoma and one specimen of lymphomatoid papulosis. These results do not 
support a role for any of these herpesviruses in the pathogenesis of 
cutaneous T-cell lymphoma. (Abstract from CANCERLIT AND EMBASE) 

============================================================ 
31.) Molecular diagnosis of lymphocytic infiltrates of the skin. 
============================================================ 
Authors 
Weinberg JM. Rook AH. Lessin SR. 
Institution 
Department of Dermatology, University of Pennsylvania, Philadelphia. 
Source 
Archives of Dermatology. 129(11):1491-500, 1993 November. 
Abstract 
BACKGROUND: Advances in our understanding of the molecular genetics of 
lymphocyte antigen receptors (B-cell immunoglobulin and T-cell antigen 
receptor), have led to the application of molecular biologic techniques to 
molecularly characterize lymphocytic infiltrates of the skin. Molecular 
diagnosis refers to the application of these techniques as a diagnostic aid 
in the clinicopathologic evaluation of cutaneous lymphocytic infiltrates. 
OBSERVATION: Molecular studies have clinical application in the 
determination of lineage and detection of retroviruses in cutaneous 
lymphoid neoplasms, distinguishing between lymphoproliferative and reactive 
infiltrates, and staging and monitoring response to therapy in cutaneous 
T-cell lymphoma. Southern blot analysis of immunoglobulin and T-cell 
antigen receptor gene rearrangements may fail to aid the clinician in 
establishing a diagnosis of a cutaneous malignancy due to the limits of 
detection sensitivity in minimally infiltrated lesions (eg, parapsoriasis 
and patch-stage mycosis fungoides) or the still uncertain prognostic 
significance of clonality in benign cutaneous diseases (eg, follicular 
mucinosis, pityriasis lichenoides et varioliformis acuta, lymphomatoid 
papulosis, and cutaneous lymphoid hyperplasia). CONCLUSIONS: Molecular 
studies have enormous research value, providing new means to explore the 
pathogenesis and clonal evolution of lymphoproliferative skin diseases. 
Presently, however, they have limited applications as an independent 
diagnostic tool. As our understanding of the clinical and biologic 
significance of the molecular detection of clonal lymphocyte populations in 
the skin expands and as the application of polymerase chain reaction 
amplification provides us with greater detection sensitivity and 
specificity, the clinical utility of molecular diagnosis of lymphocytic 
infiltrates of the skin will be enhanced. 

============================================================ 
32.) Gene rearrangements and T-cell lymphomas. 
============================================================ 
Authors 
Terhune MH. Cooper KD. 
Institution 
Department of Dermatology, University of Michigan School of Medicine, Ann 
Arbor. 
Source 
Archives of Dermatology. 129(11):1484-90, 1993 November. 
Abstract 
BACKGROUND: Cutaneous T-cell lymphomas comprise a broad spectrum of 
neoplasia ranging from indolent to highly aggressive types. To determine 
subset lineage and malignant vs benign nature, morphologic analysis, 
immunophenotyping, and flow cytometry have been used. However, given the 
shortcomings of these methods, molecular genetic techniques, which take 
particular advantage of the clonal nature of malignancy, are now being 
applied to better characterize and diagnose these lymphomas. RESULTS: Each 
antigen-specific T cell and its clonal progeny has a unique rearrangement 
of its T-cell receptor gene such that it can recognize very specific 
antigenic epitopes. By visualizing these particular T-cell receptor gene 
rearrangements, Southern hybridization techniques and polymerase chain 
reaction amplification can detect clonal populations of T cells in the 
skin, blood, and lymph nodes of patients with T-cell leukemias and 
lymphomas. Clonal T-cell populations have also been found in cases of 
benign disorders such as lymphomatoid papulosis and pityriasis lichenoides 
et varioliformis acuta. Although these disorders usually have a benign 
outcome, they may represent dysplastic clonal lymphoid expansions with a 
high incidence of spontaneous regression. CONCLUSIONS: Molecular genetic 
techniques have added to our ability to diagnose, characterize, and monitor 
the course of T-cell lymphomas and leukemias. In addition, they may provide 
insight into the pathogenesis of certain benign disorders. 

============================================================ 
33.)Lymphomatoid papulosis associated with pityriasis lichenoides et 
varioliformis acuta with transition in a large-cell anaplastic cutaneous 
Ki-1 lymphoma. Treatment with alpha-interferon 
============================================================ 
AU: Hilbert-E; Detmar-M; Gollnick-H; Bruchhauser-U; Orfanos-CE 
SO: Z-HAUTKR. 67/9 (832) 1992 
CO: ZHKRA 
PY: 1992 
LA: German 
CP: Federal-Republic-of-Germany 
PT: Journal-Article 

============================================================ 
34.) Pityriasis lichenoides chronica with acral distribution mimicking 
palmoplantar syphilid. 
============================================================ 
Acta Derm Venereol 1999 May;79(3):239 

Chung HG, Kim SC 
Publication Types: 

Letter 
============================================================ 
============================================================ 
35.) Pityriasis lichenoides and acquired toxoplasmosis. 
============================================================ 
Int J Dermatol 1999 May;38(5):372-4 

Rongioletti F, Delmonte S, Rebora A 
Department of Dermatology, University of Genoa, Italy. 
============================================================ 
============================================================ 
36.) Paraneoplastic pityriasis lichenoides chronica. 
============================================================ 
J Eur Acad Dermatol Venereol 1999 Mar;12(2):189-90 

Lazarov A, Lalkin A, Cordoba M, Lishner M 
Letter 
============================================================ 
============================================================ 
37.) Cutaneous T-cell lymphoma presenting with 'segmental pityriasis lichenoides 
chronica'. 
============================================================ 
Clin Exp Dermatol 1998 Sep;23(5):232 

Child FJ, Fraser-Andrews EA, Russell-Jones R 
Publication Types: 

Letter 
============================================================ 
============================================================ 
38.) Successful long-term use of cyclosporin A in HIV-induced pityriasis 
lichenoides chronica [letter] 
============================================================ 
Author 
Griffiths JK 
Source 
J Acquir Immune Defic Syndr Hum Retrovirol, 18(4):396-7 1998 Aug 1 
============================================================ 
============================================================ 
39.) Pityriasis lichenoides chronica resolving after tonsillectomy. 
============================================================ 
Br J Dermatol 1993 Sep;129(3):353-4 

Takahashi K, Atsumi M 
Publication Types: 
Letter 
============================================================ 
============================================================ 
40.) Segmental pityriasis lichenoides chronica. 
============================================================ 
Clin Exp Dermatol 1996 Nov;21(6):464-5 

Cliff S, Cook MG, Ostlere LS, Mortimer PS 
Publication Types: 

Letter 
============================================================ 
============================================================ 
41.) Pityriasis lichenoides et varioliformis acuta and group-A beta 
hemolytic streptococcal infection. 
============================================================ 
AU: English-JC-3rd; Collins-M; Bryant-Bruce-C 
AD: Department of Primary Care and Community Medicine, USA MEDDAC, Ft. 
Campbell, Kentucky 42223-5349, USA. 
SO: Int-J-Dermatol. 1995 Sep; 34(9): 642-4 

================================================================== 
DATA-MEDICOS/DERMAGIC-EXPRESS No 2-(85)  11/12/1.999 DR. JOSE LAPENTA R. 
=================================================================== 

  Produced by Dr. Jose Lapenta R. Dermatologist 
                 Maracay Estado Aragua Venezuela 1.999  
           Telf: 0416-6401045- 02432327287-02432328571